Collagen hydrolysate for use in prevention and/or treatment of post intensive care syndrome (pics)

Cell-protecting composition containing cyclo histidine-proline as active ingredient

Dietary Supplement Comprising Beta-Glucan and Casein Hydrolysate for Improving Health and Growth Performance in a Mammal

Composition for cell protection containing cyclo histidine-proline as active ingredient

System and method of estimating livestock weight

NUTRITIONAL FORMULATIONS COMPRISING A PEA PROTEIN ISOLATE

Composition for cell protection containing cyclo histidine-proline as active ingredient

Lipid composition for use in infants and young children for promoting gut comfort and optimal fat and calcium absorption

COMPOSITION CONTAINING CAFFEINE AND CYCLOALANYLALANINE

ORAL REHYDRATION COMPOSITION AND METHODS THEREOF

High caloric, high protein nutritional formula comprising collagen

Composition containing amino acids and process for producing same

Glycine for use in tolerance induction in allergic patients

Compositions and Formulations and Methods of Production and Use Thereof

Use of Glycomacropeptide to Improve Women's Health

Method for preparing inhibited starch with improved warehouse storage stability

Cheese and method for producing the same

Hydrogel-forming material

Partially hydrolyzed casein-whey nutritional compositions for reducing the onset of allergies

Supplement for Strengthening the Muscles of a Human

Method for enzymatically preparing peptides for use in improvement of brain function

PROCESS FOR PREPARING CASEIN-DERIVED PEPTIDES BY FERMENTATION OF LACTIC ACID BACTERIA

Inhibitor against forming biofilm comprising κ-casein macropeptide

Bioactive pentapeptides from rice bran and use thereof

Probiotic Stabilization

USE OF GLP-1 AS A THERAPEUTIC AGENT

USE OF INSULIN C-PEPTIDE, ALONE OR IN COMBINATION WITH GLP-1, AS A THERAPEUTIC AGENT

USE OF A PEPTIDE AS A THERAPEUTIC AGENT

TRAP-14 AS A THERAPEUTIC AGENT

USE OF THE PEPTIDE COMBINATION THYMOSIN BETA 4 AND DELTA SLEEP INDUCING PEPTIDE AS A THERAPEUTIC AGENT

USE OF PEPTIDE LL-37 AS A THERAPEUTIC AGENT

USE OF A PEPTIDE AS A THERAPEUTIC AGENT

USE OF A PEPTIDE AS A THERAPEUTIC AGENT

USE OF THE PEPTIDE HIS-SER-LEU-GLY-LYS-TRP-LEU-GLY-HIS-PRO-ASP-LYS-PHE ALONE OR IN COMBINATION WITH THE PEPTIDE GLY-ARD-GLY-ASP-ASN-PRO-OH AS A THERAPEUTIC AGENT

USE OF GRF-1 (1-29 ) AND CORTICOTROPIN-RELEASING FACTOR AS THERAPEUTIC AGENTS

CGRP AS A THERAPEUTIC AGENT

USE OF STRESSCOPIN-RELATED PEPTIDE AS A THERAPEUTIC AGENT

USE OF A PEPTIDE AS A THERAPEUTIC AGENT

USE OF THE PEPTIDE HIS-SER-LEU-GLY-LYS-TRP-LEU-GLY-HIS-PRO-ASP-LYS-PHE ALONE OR IN COMBINATION WITH THE PEPTIDE PRO-GLY-THR-CYS-GLU-ILE-CYS-ALA-TYR-ALA-ALA-CYS-THR-GLY-CYS-OH AS A THERAPEUTIC AGENT

USE OF A PEPTIDE AS A THERAPEUTIC AGENT

USE OF SECRETIN AND OPTIONALLY URODILATIN AS THERAPEUTIC AGENTS

Use of Peptide YY, alone or in combination with glucagon-like peptide, for use in medicine

THERAPEUTIC USES OF B-TYPE NATRIURETIC PEPTIDE AND HUMAN GROWTH HORMONE 1-43

USE OF A PEPTIDE AS A THERAPEUTIC AGENT

PROADRENOMEDULLIN ALONE OR IN COMBINATION WITH BIG GASTRIN I AS A THERAPEUTIC AGENT

VASODILATOR PHARMACEUTICAL PREPARATION AND HEALTH FOOD COMPOSITION

Peptides with anti-hypertensive properties